findmyKOL
Clinical trialNCT02640586UnknownInterventional

Predicting Neoadjuvant Therapy Response of Rectal Cancer With MRI

SponsorSun Ying-ShiEnrollment1,614Rectal Neoplasms
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • Beijing Chao Yang Hospital

    Beijing, Beijing Municipality, China

  • Beijing Friendship Hospital Capital Medical University

    Beijing, Beijing Municipality, China

  • Chinese Academy of Medical Sciences, Cancer Hospital & Institute

    Beijing, Beijing Municipality, China

  • Peking University Cancer Hospital

    Beijing, Beijing Municipality, China

  • the First Affiliated Hospital of Chongqing Medical University

    Chongqing, Chongqing Municipality, China

  • Guangxi Cancer Hospital

    Guilin, Guangxi, China

  • Hubei Cancer Hospital

    Wuhan, Hubei, China

  • Hunan Cancer Hospital

    Changsha, Hunan, China

  • Jilin Cancer Hospital

    Changchun, Jilin, China

  • the First Affiliated Hospital of Jilin University

    Changchun, Jilin, China

  • Shanxi Cancer Hospital

    Taiyuan, Shanxi, China

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
10 Jan 2016
Primary completion
17 Jul 2020
Completion
31 Dec 2023
Last update posted
22 Jun 2023
Registered enrollment
1,614
Registry id
NCT02640586

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.